Product
Levoketoconazole
Aliases
COR-003
Name
Recorlev
INN Name
Levoketoconazole
FDA Approved
Yes
2 clinical trials
1 organization
3 indications
1 document
Indication
Cushing's SyndromeIndication
Cushing's syndromeIndication
Cushing diseaseClinical trial
An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's SyndromeStatus: Completed, Estimated PCD: 2022-12-31
Clinical trial
A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's SyndromeStatus: Completed, Estimated PCD: 2020-06-30
Document
DailyMed Label: RecorlevOrganization
Xeris Pharmaceuticals, Inc.